Fig. 5

Numbers and relative percentages of AD, BC and PC projects that focused on drugs, treatments or medical devices (A) or on drug development, testing or repurposing (B), across framework programmes (FP5, FP6, FP7 and H2020) that accounted for the use of animals alone or in combination with other non-animal methods (orange bars) or based exclusively on non-animal methods and technologies (green bars). Y axis reports percentage values, whilst absolute project numbers are reported inside bars